Zobrazeno 1 - 10
of 384
pro vyhledávání: '"Hiromichi Mizuno"'
Autor:
LiveWire Group, Inc.
Publikováno v:
Business Wire (English). 06/08/2023.
Autor:
Naoki Kohira, Meredith A Hackel, Merime Oota, Miki Takemura, Fupin Hu, Hiromichi Mizuno, Daniel F Sahm, Yoshinori Yamano
Publikováno v:
Journal of Global Antimicrobial Resistance. 32:181-186
Cefiderocol (CFDC) is a parenteral siderophore cephalosporin that is active against Gram-negative bacteria, including carbapenem-resistant isolates. We report the in vitro activity of CFDC and other antibiotics against 1,738 clinical isolates of Gram
Publikováno v:
AiCIO News. 3/27/2020, pN.PAG-N.PAG. 1p.
Autor:
MSCI Inc.
Publikováno v:
Business Wire (German). 08/01/2023.
Autor:
MSCI Inc.
Publikováno v:
Business Wire (Español). 08/01/2023.
Autor:
MSCI Inc.
Publikováno v:
Business Wire (English). 08/01/2023.
Autor:
Kusuki Nishioka, Kenichi Osada, Hiromichi Mizuno, Masato Murakami, Hisao Ichibayashi, Mitsuhiro Ishida, Toshimitsu Ochiai, Levent Alev
Publikováno v:
Modern Rheumatology. 27:688-695
Objectives: We aimed to evaluate the long-term safety and efficacy of duloxetine 60 mg in Japanese patients with fibromyalgia enrolled from a preceding randomized, placebo-controlled, phase III duloxetine trial. Methods: This was a long-term, open-la
Publikováno v:
CIO&Leader. 3/12/2024, pN.PAG-N.PAG. 1p.
Autor:
Masato Murakami, Kenichi Osada, Hisao Ichibayashi, Hiromichi Mizuno, Toshimitsu Ochiai, Mitsuhiro Ishida, Alev, Levent, Kusuki Nishioka
Publikováno v:
Modern Rheumatology; 2017, Vol. 27 Issue 4, p688-695, 8p
Autor:
Hiromichi Mizuno, Masato Murakami, Levent Alev, Toshimitsu Ochiai, Kenichi Osada, Kusuki Nishioka
Publikováno v:
Arthritis Research & Therapy
Introduction Fibromyalgia is characterized by widespread pain and is often accompanied by accessory symptoms. There are limited treatment options for this condition in Japan. Therefore, we conducted a phase III study to assess the efficacy and safety